期刊
HEART FAILURE CLINICS
卷 15, 期 4, 页码 487-+出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.hfc.2019.06.010
关键词
Hypertension; Cardio-oncology; Cardiotoxicity; Heart failure; Vascular endothelial growth factor signaling pathway inhibitor
As cancer therapies improve, the population of survivors of cancer has increased, and the long-term effects of cancer treatments have become more apparent. Cardiotoxicity is a well-established adverse effect of many antineoplastic agents. Hypertension is common in survivors of cancer, can be caused or worsened by certain agents, and has been shown to increase the risk of other cardiovascular diseases including heart failure. Pretreatment risk assessment and careful monitoring of blood pressure during therapy is essential. Aggressive management of preexisting or incident hypertension in survivors of cancer is paramount to decrease the risk of heart failure and other cardiovascular diseases in these patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据